Choroid Plexus Calcification Correlates with Cortical Microglial Activation in Humans: A Multimodal PET, CT, MRI Study

References

1. 1.↵
   1. Reboldi A,
   2. Coisne C,
   3. Baumjohann D, et al

   . C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009;10:514–23 doi:10.1038/ni.1716 pmid:19305396

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Kunis G,
   2. Baruch K,
   3. Rosenzweig N, et al

   . IFN-γ-dependent activation of the brain’s choroid plexus for CNS immune surveillance and repair. Brain 2013;136:3427–40 doi:10.1093/brain/awt259 pmid:24088808

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Schwartz M,
   2. Baruch K

   . The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J 2014;33:7–22 doi:10.1002/embj.201386609 pmid:24357543

   Abstract/FREE Full Text
4. 4.↵
   1. Manouchehri N,
   2. Stuve O

   . Choroid plexus volumetrics and brain inflammation in multiple sclerosis. Proc Natl Acad Sci U S A 2021;118:e2115221118 doi:10.1073/pnas.2115221118 pmid:34583997

   FREE Full Text
5. 5.↵
   1. Fleischer V,
   2. Gonzalez-Escamilla G,
   3. Ciolac D, et al

   . Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans. Proc Natl Acad Sci U S A 2021;118:e2025000118 doi:10.1073/pnas.2025000118 pmid:34479997

   Abstract/FREE Full Text
6. 6.↵
   1. Ricigliano VA,
   2. Morena E,
   3. Colombi A, et al

   . Choroid plexus enlargement in inflammatory multiple sclerosis: 3.0-T MRI and translocator protein PET evaluation. Radiology 2021;301:166–77 doi:10.1148/radiol.2021204426 pmid:34254858

   CrossRefPubMed
7. 7.↵
   1. Choi JD,
   2. Moon Y,
   3. Kim HJ, et al

   . Choroid plexus volume and permeability at brain MRI within the Alzheimer disease clinical spectrum. Radiology 2022;304:635–45 doi:10.1148/radiol.212400 pmid:35579521

   CrossRefPubMed
8. 8.↵
   1. Tadayon E,
   2. Pascual-Leone A,
   3. Press D, et al

   ; Alzheimer’s Disease Neuroimaging Initiative. Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimer’s and Parkinson’s disease. Neurobiol Aging 2020;89:108–17 doi:10.1016/j.neurobiolaging.2020.01.005 pmid:32107064

   CrossRefPubMed
9. 9.↵
   1. Alvira-Botero X,
   2. Carro EM

   . Clearance of amyloid-beta peptide across the choroid plexus in Alzheimer’s disease. Curr Aging Sci 2010;3:219–29 doi:10.2174/1874609811003030219 pmid:20735345

   CrossRefPubMed
10. 10.↵
    1. Alisch JS,
    2. Kiely M,
    3. Triebswetter C, et al

    . Characterization of age-related differences in the human choroid plexus volume, microstructural integrity, and blood perfusion using multiparameter magnetic resonance imaging. Front Aging Neurosci 2021;13:734992 doi:10.3389/fnagi.2021.734992 pmid:34603011

    CrossRefPubMed
11. 11.↵
    1. Althubaity N,
    2. Schubert J,
    3. Martins D, et al

    . Choroid plexus enlargement is associated with neuroinflammation and reduction of blood brain barrier permeability in depression. Neuroimage Clin 2022;33:102926 doi:10.1016/j.nicl.2021.102926 pmid:34972034

    CrossRefPubMed
12. 12.↵
    1. Egorova N,
    2. Gottlieb E,
    3. Khlif MS, et al

    . Choroid plexus volume after stroke. Int J Stroke 2019;14:923–30 doi:10.1177/1747493019851277 pmid:31096870

    CrossRefPubMed
13. 13.↵
    1. Živković VS,
    2. Stanojković MM,
    3. Antić MM

    . Psammoma bodies as signs of choroid plexus ageing: a morphometric analysis. Vojnosanitetski Pregled 2017;74:1054–59 doi:10.2298/VSP160321205Z

    CrossRef
14. 14.↵
    1. Alcolado JC,
    2. Moore IE,
    3. Weller RO

    . Calcification in the human choroid plexus, meningiomas and pineal gland. Neuropathol Appl Neurobiol 1986;12:235–50 doi:10.1111/j.1365-2990.1986.tb00137.x pmid:3736772

    CrossRefPubMed
15. 15.↵
    1. Wolburg H,
    2. Paulus W

    . Choroid plexus: biology and pathology. Acta Neuropathol 2010;119:75–88 doi:10.1007/s00401-009-0627-8 pmid:20033190

    CrossRefPubMed
16. 16.↵
    1. Emerich DF,
    2. Skinner SJ,
    3. Borlongan CV, et al

    . The choroid plexus in the rise, fall and repair of the brain. Bioessays 2005;27:262–74 doi:10.1002/bies.20193 pmid:15714561

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Dyke CG

    . Indirect signs of brain tumor as noted in routine roentgen examinations: displacement of the pineal shadow (a survey of 3000 consecutive skull examinations). AJR Am J Roentgenol 1930;23:598–606
18. 18.↵
    1. Modic M,
    2. Weinstein M,
    3. Rothner A, et al

    . Calcification of the choroid plexus visualized by computed tomography. Radiology 1980;135:369–72 doi:10.1148/radiology.135.2.7367628 pmid:7367628

    CrossRefPubMed
19. 19.↵
    1. Nicolas G,
    2. Charbonnier C,
    3. Campion D, et al

    . Estimation of minimal disease prevalence from population genomic data: application to primary familial brain calcification. Am J Med Genet B Neuropsychiatr Genet 2018;177:68–74 doi:10.1002/ajmg.b.32605 pmid:29152850

    CrossRefPubMed
20. 20.↵
    1. Adams LC,
    2. Bressem K,
    3. Böker SM, et al

    . Diagnostic performance of susceptibility-weighted magnetic resonance imaging for the detection of calcifications: a systematic review and meta-analysis. Sci Rep 2017;7:15506 doi:10.1038/s41598-017-15860-1 pmid:29138506

    CrossRefPubMed
21. 21.↵
    1. Wehrli FW

    . Magnetic resonance of calcified tissues. J Magn Reson 2013;229:35–48 doi:10.1016/j.jmr.2012.12.011 pmid:23414678

    CrossRefPubMed
22. 22.↵
    1. Wen Y,
    2. Spincemaille P,
    3. Nguyen T, et al

    . Multiecho complex total field inversion method (mcTFI) for improved signal modeling in quantitative susceptibility mapping. Magn Reson Med 2021;86:2165–78 doi:10.1002/mrm.28814 pmid:34028868

    CrossRefPubMed
23. 23.↵
    1. Kreisl WC,
    2. Kim MJ,
    3. Coughlin JM, et al

    . PET imaging of neuroinflammation in neurological disorders. Lancet Neurol 2020;19:940–50 doi:10.1016/S1474-4422(20)30346-X pmid:33098803

    CrossRefPubMed
24. 24.↵
    1. Guilarte TR,
    2. Rodichkin AN,
    3. McGlothan JL, et al

    . Imaging neuroinflammation with TSPO: a new perspective on the cellular sources and subcellular localization. Pharmacol Ther 2022;234:108048 doi:10.1016/j.pharmthera.2021.108048 pmid:34848203

    CrossRefPubMed
25. 25.↵
    1. Jain P,
    2. Chaney AM,
    3. Carlson ML, et al

    . Neuroinflammation PET imaging: current opinion and future directions. J Nucl Med 2020;61:1107–12 doi:10.2967/jnumed.119.229443 pmid:32620705

    Abstract/FREE Full Text
26. 26.↵
    1. Janssen B,
    2. Vugts DJ,
    3. Windhorst AD, et al

    . PET imaging of microglial activation: beyond targeting TSPO. Molecules 2018;23:607 doi:10.3390/molecules23030607 pmid:29518005

    CrossRefPubMed
27. 27.↵
    1. Hughes AJ,
    2. Daniel SE,
    3. Kilford L, et al

    . Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181–84 doi:10.1136/jnnp.55.3.181 pmid:1564476

    Abstract/FREE Full Text
28. 28.↵
    1. Jenkinson M,
    2. Bannister P,
    3. Brady M, et al

    . Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825–41 doi:10.1006/nimg.2002.1132 pmid:12377157

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Woolrich MW, et al

    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23:S208–19 doi:10.1016/j.neuroimage.2004.07.051 pmid:15501092

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Butler T,
    2. Li Y,
    3. Tsui W, et al

    . Transient and chronic seizure-induced inflammation in human focal epilepsy. Epilepsia 2016;57:e191–94 doi:10.1111/epi.13457 pmid:27381590

    CrossRefPubMed
31. 31.↵
    1. Schubert J,
    2. Tonietto M,
    3. Turkheimer F, et al

    . Supervised clustering for TSPO PET imaging. Eur J Nucl Med Mol Imaging 2021;49:257–68 doi:10.1007/s00259-021-05309-z pmid:33779770

    CrossRefPubMed
32. 32.↵
    1. Wimberley C,
    2. Lavisse S,
    3. Hillmer A, et al

    . Kinetic modeling and parameter estimation of TSPO PET imaging in the human brain. Eur J Nucl Med Mol Imaging 2021;49:246–56 doi:10.1007/s00259-021-05248-9 pmid:33693967

    CrossRefPubMed
33. 33.↵
    1. Fischl B,
    2. Salat DH,
    3. Busa E, et al

    . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341–55 doi:10.1016/s0896-6273(02)00569-x pmid:11832223

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Yalcin A,
    2. Ceylan M,
    3. Bayraktutan OF, et al

    . Age and gender related prevalence of intracranial calcifications in CT imaging; data from 12,000 healthy subjects. J Chem Neuroanat 2016;78:20–24 doi:10.1016/j.jchemneu.2016.07.008 pmid:27475519

    CrossRefPubMed
35. 35.↵
    1. Avants BB,
    2. Tustison NJ,
    3. Song G, et al

    . A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 2011;54:2033–44 doi:10.1016/j.neuroimage.2010.09.025 pmid:20851191

    CrossRefPubMed
36. 36.↵
    1. Sethian JA

    . Level Set Methods and Fast Marching Methods: Evolving interfaces in computational geometry, fluid mechanics, computer vision, and materials science. Cambridge University Press; 1999
37. 37.↵
    1. Arthur D,
    2. Vassilvitskii S

    . k-means++ the advantages of careful seeding. Proceedings of the eighteenth annual ACM-SIAM symposium on Discrete algorithms (2007, January, pp 1027–1035).
38. 38.↵
    1. Tuisku J,
    2. Plavén-Sigray P,
    3. Gaiser EC, et al

    ; HRRT [11C] PBR28 Study Group. Effects of age, BMI and sex on the glial cell marker TSPO: a multicentre [¹¹C] PBR28 HRRT PET study. Eur J Nucl Med Mol Imaging 2019;46:2329–38 doi:10.1007/s00259-019-04403-7 pmid:31363804

    CrossRefPubMed
39. 39.↵
    1. Al-Zaghal A,
    2. Seraj SM,
    3. Werner TJ, et al

    . Assessment of physiologic intracranial calcification in healthy adults using 18F-NaF PET/CT. J Nucl Med 2018 Jul 12. [Epub ahead of print] doi:10.2967/jnumed.118.213678

    Abstract/FREE Full Text
40. 40.↵
    1. Patel DV,
    2. Holfels EM,
    3. Vogel NP, et al

    . Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology 1996;199:433–40 doi:10.1148/radiology.199.2.8668790 pmid:8668790

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Suridjan I,
    2. Rusjan P,
    3. Voineskos AN, et al

    . Neuroinflammation in healthy aging: a PET study using a novel translocator protein 18 kDa (TSPO) radioligand, [18F]-FEPPA. Neuroimage 2014;84:868–75 doi:10.1016/j.neuroimage.2013.09.021 pmid:24064066

    CrossRefPubMed
42. 42.↵
    1. Owen DR,
    2. Yeo AJ,
    3. Gunn RN, et al

    . An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab 2012;32:1–5 doi:10.1038/jcbfm.2011.147 pmid:22008728

    CrossRefPubMed
43. 43.↵
    1. Gerhard A

    . TSPO imaging in parkinsonian disorders. Clin Transl Imaging 2016;4:183–90 doi:10.1007/s40336-016-0171-1 pmid:27340650

    CrossRefPubMed
44. 44.↵
    1. Zhang PF,
    2. Gao F

    . Neuroinflammation in Parkinson’s disease: a meta-analysis of PET imaging studies. J Neurol 2022;269:2304–14 doi:10.1007/s00415-021-10877-z pmid:34724571

    CrossRefPubMed
45. 45.↵
    1. Ghadery C,
    2. Koshimori Y,
    3. Coakeley S, et al

    . Microglial activation in Parkinson’s disease using [18 F]-FEPPA. J Neuroinflammation 2017;14:8 doi:10.1186/s12974-016-0778-1 pmid:28086916

    CrossRefPubMed
46. 46.↵
    1. Salter MW,
    2. Stevens B

    . Microglia emerge as central players in brain disease. Nat Med 2017;23:1018–27 doi:10.1038/nm.4397 pmid:28886007

    CrossRefPubMed
47. 47.↵
    1. Zarb Y,
    2. Sridhar S,
    3. Nassiri S, et al

    . Microglia control small vessel calcification via TREM2. Sci Adv 2021;7:eabc4898 doi:10.1126/sciadv.abc4898 pmid:34848203

    FREE Full Text
48. 48.↵
    1. Hansen DV,
    2. Hanson JE,
    3. Sheng M

    . Microglia in Alzheimer’s disease. J Cell Biol 2018;217:459–72 doi:10.1083/jcb.201709069 pmid:29196460

    Abstract/FREE Full Text
49. 49.↵
    1. Gui Y,
    2. Marks JD,
    3. Das S, et al

    . Characterization of the 18 kDa translocator protein (TSPO) expression in post‐mortem normal and Alzheimer’s disease brains. Brain Pathol 2020;30:151–64 doi:10.1111/bpa.12763 pmid:31276244

    CrossRefPubMed
50. 50.↵
    1. Notter T,
    2. Schalbetter SM,
    3. Clifton NE, et al

    . Neuronal activity increases translocator protein (TSPO) levels. Mol Psychiatry 2021;26:2025–37 doi:10.1038/s41380-020-0745-1 pmid:32398717

    CrossRefPubMed
51. 51.↵
    1. Mildenberger W,
    2. Stifter SA,
    3. Greter M

    . Diversity and function of brain-associated macrophages. Curr Opin Immunol 2022;76:102181 doi:10.1016/j.coi.2022.102181 pmid:35462276

    CrossRefPubMed